15-49371309-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152647.3(FAM227B):c.1103C>A(p.Ala368Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000762 in 1,574,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152647.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM227B | NM_152647.3 | c.1103C>A | p.Ala368Glu | missense_variant | 12/16 | ENST00000299338.11 | NP_689860.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM227B | ENST00000299338.11 | c.1103C>A | p.Ala368Glu | missense_variant | 12/16 | 2 | NM_152647.3 | ENSP00000299338 | P1 | |
FAM227B | ENST00000559573.3 | n.413C>A | non_coding_transcript_exon_variant | 3/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152018Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000156 AC: 38AN: 243678Hom.: 0 AF XY: 0.000189 AC XY: 25AN XY: 131952
GnomAD4 exome AF: 0.0000815 AC: 116AN: 1422670Hom.: 0 Cov.: 24 AF XY: 0.000113 AC XY: 80AN XY: 709650
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152018Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2023 | The c.1103C>A (p.A368E) alteration is located in exon 12 (coding exon 11) of the FAM227B gene. This alteration results from a C to A substitution at nucleotide position 1103, causing the alanine (A) at amino acid position 368 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at